GreenBank Approves Private Placement

Toronto, Ontario, February 2, 2017 – GreenBank Capital Inc (CSE: GBC and OTCMKTS: GRNBF) (“GreenBank or the Company”) announces that the Company has agreed to a non-brokered private placement (the “Private Placement”) in which Sammiri Capital Inc, a company owned by Daniel Wettreich, CEO and a director of the Company, and David Lonsdale a director, will invest a total of $110,000 by subscribing for 2,200,000 units (each a “Unit”) of GreenBank at a price of $0.05 per Unit. Each Unit consists of one common share in the capital of GreenBank and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire one additional common share in the capital of GreenBank at an exercise price of $0.05 for 36 months after closing. The securities are subject to a hold period of four months and a day.

Upon closing of the Private Placement, GreenBank will have 20,902,460 issued and outstanding shares, and Daniel Wettreich directly and indirectly will beneficially own 16,341,198 common shares of GreenBank, representing 78.12% of GreenBank and 2,000,000 common share purchase warrants representing 53.19% of the outstanding warrants of GreenBank. In the event that all the warrants were exercised by Daniel Wettreich he would directly and indirectly beneficially own 18,341,198 common shares of GreenBank representing 80.01% of the increased share capital of 22,902,460 common shares.

Upon closing of the Private Placement, David Lonsdale will beneficially own 1,140,200 common shares of GreenBank, representing 5.45% of GreenBank and 1,000,000 common share purchase warrants representing 26.6% of the outstanding warrants of GreenBank. In the event that all the warrants were exercised by David Lonsdale he would beneficially own 2,140,200 common shares of GreenBank representing 9.77% of the increased share capital.

The proceeds of the Private Placement will be used for working capital purposes to make payments to GreenBank’s creditors.

Neither GreenBank nor Daniel Wettreich nor David Lonsdale have any knowledge of any material information concerning the Company or its securities that have not been generally disclosed. The process of approving the private placement involved the appointment of a special committee, the approval of the transaction by the special committee, the consideration of the transaction by the directors with Daniel Wettreich and David Lonsdale disclosing their interest, and the unanimous approval of the transaction by the directors. The special committee was comprised of one director who is independent within the meaning
of MI 61-101.There are three directors who are independent within the meaning of MI 61-101.

The participation by Sammiri Capital Inc, a private company owned by Daniel Wettreich, and by David Lonsdale a director, in the Private Placement is considered to be a related party transaction as defined in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). A special committee established by the board of directors and consisting of an independent director determined that the related party transaction is fair and reasonable in the circumstances to the Company. The Company has relied on sections 5.5(b) and (c) of MI 61-101 for an exemption from the formal valuation requirement, and section 5.7(b) of MI 61-101 for an exemption from the minority shareholder approval requirements. A material change report in respect of the related party transaction will be filed at least 21 days in advance of the closing of the Private Placement.

About GreenBank

GreenBank is a Canadian public company (trading symbols CSE:GBC and OTCMKTS:GRNBF). Its 80% subsidiary GreenCoinX Limited, a UK company, has developed the world’s first cryptocurrency and blockchain requiring user identification. GreenBank’s 100% subsidiary GreenBank Financial Inc. is a merchant bank.

For more information please see www.GreenBankCapitalinc.com or www.GreenCoinX.com or contact Danny Wettreich at (647) 931 9768 or by email dw@GreenBankCapitalinc.com .

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc., raising additional capital and the future development of of GreenCoinX. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release

Business Rock Stars Interviews GreenCoinX CEO Danny Wettreich About the GreenCoinX Cryptocurrency

For more information about GreenBank Capital and Danny Wettreich or GreenCoinX follow these links.

GreenCoinX = http://www.greencoinx.com/
GreenBank Capital = http://www.greenbankcapital.com/

GreenBank Approves Private Placement

Toronto, Ontario, October 3, 2014 – GreenBank Capital Inc. (CSE:GBC) (“GreenBank” or “the Company”) announces that the Company has agreed to a non-brokered private placement (the “Private Placement”) with Daniel Wettreich, a director of the Company, of 2,000,000 units (each a “Unit”) of GreenBank at a price of $0.05 per Unit, for gross proceeds of $100,000. Each Unit consists of one common share in the capital of GreenBank and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire one additional common share in the capital of GreenBank at an exercise price of $0.05, for 36 months after closing. The securities are subject to a hold period of four months and a day. The proceeds of the Private Placement will be used for working capital purposes. Upon closing of the Private Placement, Daniel Wettreich directly and indirectly will beneficially own 4,287,198 common shares of GreenBank, representing 38.47% of GreenBank and 2,000,000 common share purchase warrants representing 95% of the outstanding warrants of GreenBank.

The participation by Daniel Wettreich in the Private Placement is considered to be a related party transaction as defined in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). A special committee consisting of an independent director established by the board of directors determined the related party transaction is fair and reasonable in the circumstances to the Company. The Company has relied on sections 5.5(b) and (c) of MI 61-101 for an exemption from the formal valuation requirement, and section 5.7(b) of MI 61-101 for an exemption from the minority shareholder approval requirements. A material change report in respect of the related party transaction will not be filed at least 21 days in advance of the closing of the Private Placement due to the Company’s immediate need to address its financial situation, which omission is both reasonable and fair in the circumstances. MI 61-101 requires if a material change report is filed less than 21 days before the expected date of the closing of the transaction, an explanation is to be provided as to why the shorter period is reasonable or necessary in the circumstances.

Following the private placement GreenBank will have 11,142,460 common shares issued and outstanding.

About GreenBank

GreenBank is a corporate finance investment business investing in small cap companies, and private equity investments, and its subsidiary GreenBank Financial has applied for an exempt market dealer licence. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Acquires GreenCoin Cryptocurrency Software

Toronto, Ontario, June 11, 2014 – GreenBank Capital Inc (CSE: GBC) (“GreenBank”) is pleased to announce that it has signed a definitive agreement (“Agreement”) to acquire all the rights, title and interest to the GreenCoin cryptocurrency software. When all aspects of the GreenCoin software are completed, GreenCoin will be a new innovative cryptocurrency featuring digital identification that aims to resolve the “trust based concerns” with other virtual currencies.

Users of other cryptocurrencies are not identifiable and therefore those cryptocurrencies are not only susceptible to be used for illegal purposes, but are not easily taxable by governments. These concerns make global acceptance of cryptocurrency transactions more difficult. GreenCoin will provide a solution by adding email, or phone identification to all GreenCoin transactions. Those intending illegal activities will not use GreenCoin as they can be easily identified. Global governments will be able to collect taxes based on GreenCoin transactions with rules for each type of transaction.

GreenBank’s newly formed subsidiary GreenCoin Inc, which now owns all the rights, title and interest to GreenCoin, intends to complete the software by adding additional features to the GreenCoin software protocol, prior to launching it on the market. Upon launch it will commence an awareness and marketing campaign for GreenCoin. At that time Greencoin Inc will seek to add GreenCoin miners and GreenCoin retail users and create a GreenCoin network, and will seek acceptance of GreenCoin by governments and banking institutions.

GreenBank owns 75% of GreenCoin Inc, the lead developer Nilam Doctor owns 5%, and First Cyberking Network Limited (“FCN”) which has participated in the development of Greencoin owns 20%. GreenBank’s CEO, Danny Wettreich, has been appointed Chairman and CEO of GreenCoin Inc, and FCN’s CEO, Maxime Ngan, has been appointed a Director and Vice Chairman. Other directors of GreenCoin Inc are Nilam Doctor who is Chief Technology Officer, Paul Cullingham and Mark Wettreich.

Mr Ngan is an entrepreneur and investor based in Mauritius with business interests in telecommunications, shipping, and hotels. Mr Doctor is the lead developer of GreenCoin and a technology consultant and programmer. He is a Grant Committee Member of the Bitcoin Foundation and has assisted in multiple cryptocurrency projects.

“As an identified digital cryptocurrency, I believe that GreenCoin will represent a big step forward in the effort to resolve governmental concerns and users trust issues” said Danny Wettreich, CEO of GreenBank.

“We are delighted to be working with GreenBank to complete the development of GreenCoin and launch it on the market” said Maxime Ngan, CEO of FCN.

GreenCoin Inc is a software development company developing a unique cryptocurrency product featuring digital identification. GreenCoin has not yet been launched on the market. Securities regulatory authorities in Canada, including the Ontario Securities Commission, have yet to determine the impact of an investment product that invests in cryptocurrencies, including whether or not cryptocurrencies constitute a suitable asset class for retail investors. Upon the launch of the GreenCoin cryptocurrency on the market an investment manager registration or a dealer registration may or may not be required, and if required there is no guarantee that such registration applications if made would be granted. GreenBank has previously filed on Sedar on March 27, 2014 a Material Change Report containing disclosures with regard to the risk of investing in cryptocurrencies, and has filed today a further Material Change Report adding to such disclosures with respect to GreenCoin. There is no guarantee that the GreenCoin software will be completed, and if completed will be utilized in the market, and if utilized will be successful.

About GreenBank

GreenBank is a corporate finance investment business investing in the medical marijuana space, bitcoin startups, and Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. GreenBank also owns www.MarijuanaForCanada.ca a web based information source for the Canadian medical marijuana industry. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank To Apply For Exempt Market Dealer License

Appoints new Officer and new Director and Grants Stock Options

Toronto, Ontario, May 28, 2014 – GreenBank Capital Inc (CSE: GBC) (“GreenBank”) announces that it will apply for an Exempt Market Dealer License so that it can commence investment banking transactions. The license application will be made to the Ontario Securities Commission and there is no assurance that such a license will be granted.

“Becoming a registered exempt market securities dealer will enable GreenBank to be a dealer or underwriter for any securities which are prospectus exempt, and to be a dealer for any securities provided they are sold to clients who qualify for the purchase of exempt securities.“ said Danny Wettreich, CEO of GreenBank.

In furtherance of the license application, Paul Cullingham, currently an independent director of GreenBank, has been appointed a Vice President of the Company. Mr. Cullingham has been a licensed investment professional for over 25 years and will be the Chief Compliance Officer for the investment banking activities of GreenBank.

GreenBank is pleased to announce that Ryan Hunter has been appointed an independent director and member of the Audit Committee of the Company. Mr Hunter is a securities and corporate finance attorney with Chitiz Pathak LLP in Toronto. GreenBank has agreed to grant Mr. Hunter 60,000 incentive stock options exercisable at a price of $0.11 per share for 24 months from the date of grant.

About GreenBank

GreenBank is a corporate finance investment business investing in the medical marijuana space, bitcoin startups, and Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. GreenBank also owns www.MarijuanaForCanada.ca a web based information source for the Canadian medical marijuana industry. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

SNNLive Interview With GreenBank Capital Inc.

Las Vegas, NV, SNNLive spoke with Danny Wettreich, Chairman and CEO of GreenBank Capital, Inc. (Canadian Stock Exchange “CSE”: GBC) at the Inaugural Growth Capital Expo 2014.

Website: http://www.greenbankcapitalinc.com/

GreenBank Launches MarijuanaForCanada.ca Website

Toronto, Ontario, April 28, 2014 – GreenBank Capital Inc (CNSX: GBC) (“GreenBank”) announces that it has launched a new website www.MarijuanaForCanada.ca aimed at the medical marijuana market.

“MarijuanaForCanada.ca will seek to be the premier Canadian website for the marijuana space. It contains general information about the plant and its medicinal attributes, the latest medical marijuana news, a section on how to find a grower, a section on how to find a doctor, a section for investors in Canadian marijuana public companies, a section to ask questions of our resident expert, and a section for marijuana literature.” commented Danny Wettreich, CEO of GreenBank.

The MarijuanaForCanada expert who will be responding to questions from the public is Dr Stefan A Hulea who is GreenBank’s medical marijuana consultant. Dr. Hulea is currently authoring a book that highlights the pain alleviation properties of medical marijuana as well as health matters directed at the general public. He has an extensive background in biochemistry and worked for over 25 years in basic and applied biomedical research. He graduated from the University of Bucharest, Romania with a B.Sc.(Hon) in Biochemistry and completed his graduate work in the Department of Biochemistry, King’s College London, England, where he earned a Ph.D. in Biochemistry.

Additional features will continue to be added to the website with the aim of providing the Canadian medical marijuana community with a premier web based information source.

About GreenBank

GreenBank is a corporate finance investment business investing in the medical marijuana space, bitcoin startups, and Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. GreenBank also owns www.MarijuanaForCanada.ca a web based information source for the Canadian medical marijuana industry. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Engages Medical Marijuana Consultant

Toronto, Ontario, April 22, 2014 – GreenBank Capital Inc (CNSX: GBC) (“GreenBank”) announces that it has engaged Dr Stefan A Hulea as medical marijuana consultant. Dr Hulea will provide medical marijuana consulting services with respect to the most appropriate marijuana plants and primary growing processes to be utilized in order to maximize the profit potential inherent in the proposed growing operations of GreenBank’s subsidiary Canada Marijuana Agricorp.

Dr. Hulea is currently authoring a book that highlights the pain alleviation properties of medical marijuana as well as health matters directed at the general public. He has an extensive background in biochemistry and worked for over 25 years in basic and applied biomedical research. He graduated from the University of Bucharest, Romania with a B.Sc.(Hon) in Biochemistry and completed his graduate work in the Department of Biochemistry, King’s College London, England, where he earned a Ph.D. in Biochemistry.

Dr. Hulea has published dozens of research papers on a variety of topics including medical marijuana as well as microbial nucleic acids metabolism, the role of complex carbohydrate-binding proteins (lectins) as mediators of host-pathogen interactions, oxidative stress and antioxidant mechanisms in plant and animal cells. In the field of applied research Dr. Hulea took part in the development of a plant extract that was used with very good results in the treatment of severe skin burns as well as some skin disorders. Dr. Hulea was previously a visiting scholar at the University of Illinois at Urbana-Champaign where he conducted research on the molecular mechanisms in cardiovascular disease.

Pursuant to his medical marijuana consulting services, Dr Hulea has been granted a common share purchase warrant entitling the holder to acquire 100,000 common shares at an exercise price of $0.125 per share for 24 months, provided however that in the event that the common shares trade on the CSE at a closing price of greater than $0.50 per share for a period of 5 consecutive trading days the Company may, in its sole discretion, accelerate the expiration date of the warrants.

“Dr Hulea has a distinguished career and his expertise will provide us with unique guidance as our medical marijuana plans evolve” said Danny Wettreich, CEO of GreenBank.

About GreenBank

GreenBank is a corporate finance investment business investing in Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Engages Wellfleet Partners As Advisors

Toronto, Ontario, April 17, 2014 – GreenBank Capital Inc (CSE: GBC) (“GreenBank”) announces that it has engaged Wellfleet Partners Inc (“Wellfleet”) as advisors and consultants with respect to fundraising strategies.

Wellfleet is a New York based boutique financial services and consulting firm, which provides small and mid-size emerging private and/or publicly traded growth companies with financial, and strategic advisory services. Wellfleet, through its funds or its managements’ investment banking relationships, engages in a variety of consulting activities related to finance, venture capital, short-term bridge loans, convertibles and related activities. Over the course of 16 years, Wellfleet has advised in over 600 transactions with publicly traded and private companies from around the globe.

“We are delighted to be working with Wellfleet as we seek to strengthen our corporate finances in anticipation of our intended application for a medical marijuana producer license and our proposed commercial medical marijuana growing operations” said Danny Wettreich, CEO of GreenBank.

About GreenBank

GreenBank is a corporate finance investment business investing in Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Targets Medical Marijuana Business

New subsidiary Canada Marijuana Agricorp Inc intends to apply for medical marijuana producer license

Toronto, Ontario, April 14, 2014 – GreenBank Capital Inc. (CSE: GBC) (“GreenBank” or “the Company”), announces that it has determined to enter the medical marijuana business and has established a new subsidiary, Canada Marijuana Agricorp Inc which has entered into an agreement to lease 20 acres of suitable land near Tweed, Ontario which it proposes to utilize for the commercial production of medical marijuana.

Canada Marijuana Agricorp intends to apply for a medical marijuana producer license under the new Marijuana for Medical Purposes Regulations Health Canada program, and aims to commence commercial medical marijuana growing operations as soon as its producer license is granted. The lease of the Tweed, Ontario land is for an initial term of three years with options to renew. Power for growing operations will be provided by solar energy, and a local consultant has been engaged to supervise growing operations. Plans are being formulated for the construction of greenhouses and storage facilities to facilitate year round production capabilities. The use of greenhouses will facilitate the growing of medical marijuana through hydroponic processes.

The market for medical marijuana in Canada is controlled by and subject to regulation, and the commercial medical marijuana industry is a new industry. Commencing April 1, 2014 the only legal access to marijuana for medical purposes will be through licensed producers. Health Canada anticipates that the number of Canadians authorized to consume medical marijuana is anticipated to be 450,000 by 2024.

“GreenBank’s subsidiary Canada Marijuana Agricorp intends to provide affordable, safe, regulated, high quality medical marijuana for medical marijuana patients in Canada seeking pain relief medication. We look forward to complying with all applicable Health Canada regulations as we establish commercial production of medical marijuana. The Canadian government predicts a $1.3 billion industry in 10 years and we intend to participate in this fast growing business opportunity” said Danny Wettreich, CEO of GreenBank.

GreenBank has previously announced its intention to make Bitcoin related investments through its subsidiary Bitcoin Angel Capital Inc. which is focused on investing in early stage Bitcoin and other cryptocurrency companies, and which has recently acquired 20% of Sovereign Bitcoin Exchange.

About GreenBank

GreenBank is a corporate finance investment business investing in Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.